Global and regional estimates of COPD prevalence: Systematic review and meta-analysis

Journal of Global Health

Volumn 5, Issue 2, 2015, Pages

  Adeloye, Davies ^a   Chua, Stephen ^a   Lee, Chinwei ^a   Basquill, Catriona ^a   Papana, Angeliki ^a   Theodoratou, Evropi ^a   Nair, Harish ^a   Gasevic, Danijela ^a   Sridhar, Devi ^a   Campbell, Harry ^a   Chan, Kit Yee ^a   Sheikh, Aziz ^a   Rudan, Igor ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICA; AGED; FEMALE; GLOBAL HEALTH; HUMAN; MALE; META ANALYSIS; MIDDLE AGED; PREVALENCE; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RURAL HEALTH; SPIROMETRY; STATISTICS AND NUMERICAL DATA; WESTERN HEMISPHERE; WORLD HEALTH ORGANIZATION;

ADULT; AFRICA; AGED; AMERICAS; FEMALE; GLOBAL HEALTH; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RURAL HEALTH; SPIROMETRY; WORLD HEALTH ORGANIZATION;

EID: 85019974371     PISSN: 20472978     EISSN: 20472986     Source Type: Journal    
DOI: 10.7189/jogh.05.020415     Document Type: Article

References (168)

1. Beaglehole R, Bonita R, Alleyne G, Horton R, Li L, Lincoln P, et al. UN High-Level Meeting on Non-Communicable Diseases: addressing four questions. Lancet. 2011;378:449-55. Medline:21665266 doi:10.1016/ S0140-6736(11)60879-9
2. Horton R. Non-communicable diseases: 2015 to 2025. Lancet. 2013;381:509-10. Medline:23410603 doi:10.1016/S0140-6736(13)60100-2
3. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370:765-73. Medline:17765526 doi:10.1016/S0140-6736(07)61380-4
4. Barnes PJ. Chronic Obstructive Pulmonary Disease: A growing but neglected global epidemic. PLoS Med.2007;4:e112. Medline:17503959 doi:10.1371/journal.pmed.0040112
5. World Health Organization. Global Burden of Disease (GBD) 2002 estimates. In: World Health Report 2004. Geneva: WHO, 2004. Available: http://www.who.int/healthinfo/global_burden_disease/estimates_regional_2002/en/. Accessed: 25 November 2015.
6. World Health Organization. Burden of COPD. Geneva: WHO, 2014. Available: http://www.who.int/respiratory/copd/burden/en/. Accessed: 25 November 2015.
7. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2197-223. Medline:23245608
8. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095-128. Medline:23245604 doi:10.1016/S0140-6736(12)61728-0
9. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006;27:397-412. Medline:16452599 doi:10.118 3/09031936.06.00025805
10. Mathers CD. Uncertainty and data availability for the global burden of disease estimates 2000-2002. In: Evidence and Information for Policy Working Paper. Geneva, Switzerland: WHO, 2005. Available: http://www.who.int/healthinfo/global_burden_disease/en/index.html. Accessed: 25 November 2015.
11. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet. 2004;364:613-20. Medline:15313363 doi:10.1016/S0140-6736(04)16855-4
12. ECRHS. European Community Respiratory Health Survey 2012. Available: http://www.ecrhs.org/. Accessed: 25 November 2015.
13. European COPD Coalition. Prevalence in EU 2014. Available: http://www.copdcoalition.eu/about-copd/prevalence. Accessed: 25 November 2015.
14. Chapman KR, Mannino DM, Soriano JB, Vermeire PA, Buist AS, Thun MJ, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J. 2006;27:188-207. Medline:16387952 doi:10.1183/09031936.06.00024505
15. Centre for Disease Control. Chronic Obstructive Pulmonary Disease among adults - United States, 2011. MMWR Morb Mortal Wkly Rep. 2012;61:938-43. Medline:23169314
16. Mehrotra A, Oluwole AM, Gordon SB. The burden of COPD in Africa: a literature review and prospective survey of the availability of spirometry for COPD diagnosis in Africa. Trop Med Int Health. 2009;14:840-8. Medline:19702594 doi:10.1111/j.1365-3156.2009.02308.x
17. Salvi SS, Manap R, Beasley R. Understanding the true burden of COPD: the epidemiological challenges. Prim Care Respir J. 2012;21:249-51. Medline:22885564 doi:10.4104/pcrj.2012.00082
18. Buist AS, Vollmer WM, Sullivan SD, Weiss KB, Lee TA, Menezes AM, et al. The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. COPD. 2005;2:277-83. Medline:17136954 doi:10.1081/COPD-57610
19. Burney P. The Burden of Obstructive Lung Disease (BOLD) study prepares for African surveys. Afr Health. 2011;33:12.
20. Kart L, Akkoyunlu ME, Bayram M, Yakar F, Kutbay Ozcelik H, Karakose F, et al. COPD: an underdiagnosed disease at hospital environment. Wien Klin Wochenschr. 2014;126:73-8. Medline:24249327 doi:10.1007/s00508-013-0458-4
21. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28:523-32. Medline:16611654 doi:10.1183/09031936.06.00124605
22. Ko FWS, Hui DSC, Lai CKW. Worldwide burden of COPD in high- and low-income countries. Part III. Asia-Pacific studies. Int J Tuberc Lung Dis. 2008;12:713-7. Medline:18544193
23. Menezes AMB, Perez-Padilla R, Jardim JRB, Muino A, Lopez MV, Valdivia G, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): A prevalence study. Lancet. 2005;366:1875-81. Medline:16310554 doi:10.1016/S0140-6736(05)67632-5
24. Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care. 2001;46:798-825. Medline:11463370
25. GOLD. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2014. Available: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014_Jun11.pdf. Accessed: 25 November 2015.
26. Hwang YI, Kim CH, Kang H-R, Shin T, Park SM, Jang SH, et al. Comparison of the prevalence of Chronic Obstructive Pulmonary Disease diagnosed by lower limit of normal and fixed ratio criteria. J Korean Med Sci. 2009;24:621-6. Medline:19654942 doi:10.3346/jkms.2009.24.4.621
27. GOLD. 2005 Update: Executive summary, global strategy for the diagnosis, management and prevention of COPD. Washington, D.C.: Global Initiative for Chronic Obstructive Lung Disease; 2005. Available: http://www.goldcopd.com. Accessed: 25 November 2015.
28. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932-46. Medline:15219010 doi:10.1183/09031936.04.00014304
29. Pellegrino R, Brusasco V, Viegi G, Crapo RO, Burgos F, Casaburi R, et al. Definition of COPD: based on evidence or opinion? Eur Respir J. 2008;31:681-2. Medline:18310402 doi:10.1183/09031936.00154307
30. Di Marco F, Tantucci C, Pellegrino G, Centanni S. Chronic obstructive pulmonary disease diagnosis: The simpler the better? Not always. Eur J Intern Med. 2013;24:199-202. Medline:23466208 doi:10.1016/j. ejim.2013.01.008
31. Mohamed Hoesein FAA, Zanen P, Lammers J-WJ. Lower limit of normal or FEV1/FVC<0.70 in diagnosing COPD: An evidence-based review. Respir Med. 2011;105:907-15. Medline:21295958 doi:10.1016/j. rmed.2011.01.008
32. Izquierdo Alonso JL, Ramos PDL, Glez-Moro JMR. The use of the lower limit of normal as a criterion for COPD excludes patients with increased morbidity and high consumption of health-care resources. Arch Bronconeumol. 2012;48:223-8. Medline:22480962 doi:10.1016/j.arbres.2012.02.007
33. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88. Medline:3802833 doi:10.1016/0197-2456(86)90046-2
34. Adeloye D, Basquill C, Papana A, Chan KY, Rudan I, Campbell H. An Estimate of the Prevalence of COPD in Africa: A systematic analysis. COPD. 2015;12:71-81. Medline:24946179 doi:10.3109/15412555.2014.908834
35. Khelafi R, Aissanou A, Tarsift S, Skander F. Epidemiology of chronic obstructive pulmonary disease in Algiers. Rev Mal Respir. 2011;28:32-40. Medline:21277472 doi:10.1016/j.rmr.2010.06.026
36. Martins P, Rosado-Pinto J, Do Ceu Teixeira M, Neuparth N, Silva O, Tavares H, et al. Under-report and underdiagnosis of chronic respiratory diseases in an African country. Allergy. 2009;64:1061-7. Medline:19210360 doi:10.1111/j.1398-9995.2009.01956.x
37. Fullerton DG, Suseno A, Semple S, Kalambo F, Malamba R, White S, et al. Wood smoke exposure, poverty and impaired lung function in Malawian adults. Int J Tuberc Lung Dis. 2011;15:391-8. Medline:21333109
38. Gathuru IM, Bunker CH, Ukoli FA, Egbagbe EE. Differences in rates of obstructive lung disease between Africans and African Americans. Ethn Dis. 2002;12:S3-S107. Medline:12477165
39. Musafiri S, van Meerbeeck J, Musango L, Brusselle G, Joos G, Seminega B, et al. Prevalence of atopy, asthma and COPD in an urban and a rural area of an African country. Respir Med. 2011;105:1596-605. Medline: 21783353 doi:10.1016/j.rmed.2011.06.013
40. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. Lancet. 2007;370:741-50. Medline:17765523 doi:10.1016/S0140-6736(07)61377-4
41. Tan WC, Lo C, Jong A, Xing L, Fitzgerald MJ, Vollmer WM, et al. Marijuana and chronic obstructive lung disease: a population-based study. CMAJ. 2009;180:814-20. Medline:19364790 doi:10.1503/cmaj.081040
42. Al-Hazmi M, Wooldrage K, Anthonisen N, Becklake M, Bowie D, Chan-Yeung M, et al. Airflow obstruction in young adults in Canada. Can Respir J. 2007;14:221-7. Medline:17551598
43. Tilert T, Dillon C, Paulose-Ram R, Hnizdo E, Doney B. Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: The National Health and Nutrition Examination Survey (NHANES) 2007-2010. Respir Res. 2013;14:103. Medline:24107140 doi:10.1186/1465-9921-14-103
44. Methvin JN, Mannino DM, Casey BR. COPD prevalence in Southeastern Kentucky: The burden of lung disease study. Chest. 2009;135:102-7. Medline:18689574 doi:10.1378/chest.08-1315
45. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic Obstructive Pulmonary Disease Surveillance: United States, 1971-2000. MMWR Surveill Summ. 2002;51 S6:1-16. Medline:12198919
46. Ford ES, Mannino DM, Wheaton AG, Giles WH, Presley-Cantrell L, Croft JB. Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: Findings from the national health and nutrition examination surveys from 1988-1994 to 2007-2010. Chest. 2013;143:1395-406. Medline: 23715520 doi:10.1378/chest.12-1135
47. Vaz Fragoso CA, Concato J, McAvay G, Van Ness PH, Rochester CL, Yaggi HK, et al. The Ratio of FEV1 to FVC as a basis for establishing Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2010;181:446-51. Medline:20019341 doi:10.1164/rccm.200909-1366OC
48. Menezes A, Macedo SC, Gigante DP, da Costa JD, Olinto MT, Fiss E, et al. Prevalence and risk factors for chronic obstructive pulmonary disease according to symptoms and spirometry. COPD. 2004;1:173-9. Medline: 17136985 doi:10.1081/COPD-120039561
49. Caballero A, Torres-Duque CA, Jaramillo C, Bolivar F, Sanabria F, Osorio P, et al. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study). Chest. 2008;133:343-9.Medline:17951621 doi:10.1378/chest.07-1361
50. Laniado-Laborin R. Smoking and Chronic Obstructive Pulmonary Disease (COPD). Parallel Epidemics of the 21st Century. Int J Environ Res Public Health. 2009;6:209-24. Medline:19440278 doi:10.3390/ijerph6010209
51. Amra B, Golshan M, Fietze I, Penzel T, Welte T. Correlation between chronic obstructive pulmonary disease and obstructive sleep apnea syndrome in a general population in Iran. J Res Med Sci. 2011;16:885-9. Medline: 22279455
52. Golshan M, Barahimi H, Nasirian K. Prevalence of chronic bronchitis and chronic respiratory symptoms in adults over the age of 35 years in Isfahan, Iran in 1998. Respirology. 2001;6:231-5. Medline:11555382 doi:10.1046/j.1440-1843.2001.00331.x
53. Golshan M, Amra B, Welte T. Sample survey of chronic obstructive pulmonary disease and associated risk factors in Isfahan, Iran. Tanaffos. 2011;10:32-6. Medline:25191373
54. Waked M, Khayat G, Salameh P. Chronic obstructive pulmonary disease prevalence in Lebanon: A cross-sectional descriptive study. Clin Epidemiol. 2011;3:315-23. Medline:22253549 doi:10.2147/CLEP.S26350
55. Daldoul H, Denguezli M, Jithoo A, Gnatiuc L, Buist S, Burney P, et al. Prevalence of COPD and tobacco smoking in Tunisia - Results from the BOLD Study. Int J Environ Res Public Health. 2013;10:7257-71. Medline:24351745 doi:10.3390/ijerph10127257
56. Al Zaabi A, Asad F, Abdou J, Al Musaabi H, Al Saiari MB, Mohammed Buhussien AS, et al. Prevalence of COPD in Abu Dhabi, United Arab Emirates. Respir Med. 2011;105:566-70. Medline:21216136 doi:10.1016/j.rmed.2010.12.008
57. Al Ghobain M, Al-Hajjaj M, Wali S. Prevalence of chronic obstructive pulmonary disease among smokers attending primary healthcare clinics in Saudi Arabia. Ann Saudi Med. 2011;31:129-33. Medline:21403413 doi:10.4103/0256-4947.77485
58. Stav D, Raz M. Prevalence of chronic obstructive pulmonary disease among smokers aged 45 and up in Israel. Isr Med Assoc J. 2007;9:800-2. Medline:18085037
59. Weiss G, Steinacher I, Lamprecht B, Schirnhofer L, Kaiser B, Sonnichsen A, et al. Detection of chronic obstructive pulmonary disease in primary care in Salzburg, Austria: findings from the real world. Respiration. 2014;87:136-43. Medline:24296512 doi:10.1159/000354796
60. Schirnhofer L, Lamprecht B, Vollmer WM, Allison MJ, Studnicka M, Jensen RL, et al. COPD prevalence in Salzburg, Austria: Results from the burden of obstructive lung disease (BOLD) study. Chest. 2007;131:29-36. Medline:17218553 doi:10.1378/chest.06-0365
61. Maio S, Sherrill DL, MacNee W, Lange P, Costabel U, Dahlen S-E, et al. The European Respiratory Society spirometry tent: A unique form of screening for airway obstruction. Eur Respir J. 2012;39:1458-67. Medline:22267757 doi:10.1183/09031936.00111910
62. Fabricius P, Lokke A, Marott JL, Vestbo J, Lange P. Prevalence of COPD in Copenhagen. Respir Med. 2011;105:410-7. Medline:20952174 doi:10.1016/j.rmed.2010.09.019
63. Hansen JG, Pedersen L, Overvad K, Omland O, Jensen HK, Sorensen HT. The prevalence of chronic obstructive pulmonary disease among Danes aged 45-84 years: population-based study. COPD. 2008;5:347-52. Medline:19353348 doi:10.1080/15412550802522635
64. Kainu A, Rouhos A, Sovijärvi A, Lindqvist A, Sarna S, Lundbäck B. COPD in Helsinki, Finland: socioeconomic status based on occupation has an important impact on prevalence. Scand J Public Health. 2013;41:570-8. Medline:23599377 doi:10.1177/1403494813484554
65. Jyrki-Tapani K, Sovijarvi A, Lundback B. Chronic obstructive pulmonary disease in Finland: Prevalence and risk factors. COPD. 2005;2:331-9. Medline:17146998 doi:10.1080/15412550500218122
66. Isoaho R, Puolijoki H, Huhti E, Kivelä SL, Laippala P, Tala E. Prevalence of chronic obstructive pulmonary disease in elderly Finns. Respir Med. 1994;88:571-80. Medline:7991881 doi:10.1016/S0954-6111(05)80004-6
67. Kanervisto M, Vasankari T, Laitinen T, Heliövaara M, Jousilahti P, Saarelainen S. Low socioeconomic status is associated with chronic obstructive airway diseases. Respir Med. 2011;105:1140-6. Medline:21459567 doi:10.1016/j.rmed.2011.03.008
68. Roche N, Dalmay F, Perez T, Kuntz C, Vergnenčgre A, Neukirch F, et al. Impact of chronic airflow obstruction in a working population. Eur Respir J. 2008;31:1227-33. Medline:18216058 doi:10.1183/09031936.00089607
69. Geldmacher H, Biller H, Herbst A, Urbanski K, Allison M, Buist AS, et al. The prevalence of chronic obstructive pulmonary disease (COPD) in Germany. Results of the BOLD study. Dtsch Med Wochenschr. 2008;133:2609. Medline:19052996 doi:10.1055/s-0028-1105858
70. Gingter C, Wilm S, Abholz H-H. Is COPD a rare disease? Prevalence and identification rates in smokers aged years and over within general practice in Germany. Fam Pract. 2009;26:3-9. Medline:19033180 doi:10.1093/fampra/cmn084
71. Schikowski T, Sugiri D, Ranft U, Gehring U, Heinrich J, Wichmann H-E, et al. Long-term air pollution exposure and living close to busy roads are associated with COPD in women. Respir Res. 2005;6:152. Medline:16372913 doi:10.1186/1465-9921-6-152
72. Sichletidis L, Tsiotsios I, Gavriilidis A, Chloros D, Kottakis I, Daskalopoulou E, et al. Prevalence of chronic obstructive pulmonary disease and rhinitis in northern Greece. Respiration. 2005;72:270-7. Medline:15942296 doi:10.1159/000085368
73. Minas M, Hatzoglou C, Karetsi E, Papaioannou AI, Tanou K, Tsaroucha R, et al. COPD prevalence and the differences between newly and previously diagnosed COPD patients in a spirometry program. Prim Care Respir J. 2010;19:363-70. Medline:20532466 doi:10.4104/pcrj.2010.00034
74. Benediktsdóttir B, Gudmundsson G, Jorundsdottir KB, Vollmer W, Gíslason T. Prevalence of COPD in Iceland-the BOLD study. Laeknabladid. 2007;93:471-7. Medline:17541146
75. Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S, Carrozzi L. Definition, epidemiology and natural history of COPD. Eur Respir J. 2007;30:993-1013. Medline:17978157 doi:10.1183/09031936.00082507
76. Vanfleteren LEGW, Franssen FME, Wesseling G, Wouters EFM. The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands. Respir Med. 2012;106:871-4. Medline:22349067 doi:10.1016/j.rmed.2012.01.008
77. van Durme YMTA, Verhamme KMC, Stijnen T, van Rooij FJA, Van Pottelberge GR, Hofman A, et al. Prevalence, incidence, and lifetime risk for the development of COPD in the elderly: The Rotterdam study. Chest. 2009;135:368-77. Medline:19201711 doi:10.1378/chest.08-0684
78. Afonso ASM, Verhamme KMC, Sturkenboom MCJM, Brusselle GGO. COPD in the general population: Prevalence, incidence and survival. Respir Med. 2011;105:1872-84. Medline:21852081 doi:10.1016/j. rmed.2011.06.012
79. Waatevik M, Skorge TD, Omenaas E, Bakke P, Gulsvik A, Johannessen A. Increased prevalence of chronic obstructive pulmonary disease in a general population. Respir Med. 2013;107:1037-45. Medline:23680166 doi:10.1016/j.rmed.2013.04.008
80. Hvidsten SC, Storesund L, Wentzel-Larsen T, Gulsvik A, Lehmann S. Prevalence and predictors of undiagnosed chronic obstructive pulmonary disease in a Norwegian adult general population. Clin Respir J. 2010;4:13-21. Medline:20298413 doi:10.1111/j.1752-699X.2009.00137.x
81. Bakke PS, Baste V, Hanoa R, Gulsvik A. Prevalence of obstructive lung disease in a general population: Relation to occupational title and exposure to some airborne agents. Thorax. 1991;46:863-70. Medline:1792631 doi:10.1136/thx.46.12.863
82. Johannessen A, Omenaas E, Bakke P, Gulsvik A. Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult population. Int J Tuberc Lung Dis. 2005;9:926-32. Medline:16104642
83. Bednarek M, Maciejewski J, Wozniak M, Kuca P, Zielinski J. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax. 2008;63:402-7. Medline:18234906 doi:10.1136/thx.2007.085456
84. Nizankowska-Mogilnicka E, Mejza F, Buist AS, Vollmer WM, Skucha W, Harat R, et al. Prevalence of COPD and tobacco smoking in Malopolska region-results from the BOLD study in Poland. Pol Arch Med Wewn. 2007;117:402-10. Medline:18062562
85. Plywaczewski R, Bednarek M, Jonczak L, Zielinski J. Prevalence of COPD in Warsaw population. Pneumonol Alergol Pol. 2003;71:329-35. Medline:15052966
86. Paprzycki P, Panasiuk L, Sodolski W. Prevalence of obstructive respiratory disorders in the rural population of the Lublin region. Ann Univ Mariae Curie Sklodowska Med. 2003;58:72-8. Medline:15314962
87. Siatkowska H, Kozielski J, Ziora D. Chronic obstructive pulmonary disease patients in the general practice.Pneumonol Alergol Pol. 2010;78:112-20. Medline:20306422
88. Bárbara C, Rodrigues F, Dias H, Cardoso J, Almeida J, Matos M, et al. Chronic obstructive pulmonary disease prevalence in Lisbon, Portugal: The burden of obstructive lung disease study. Rev Port Pneumol. 2013;19:96-105. Medline:23664024 doi:10.1016/j.rppneu.2012.11.004
89. Cardoso J, Ferreira JR, Almeida J, Santos JM, Rodrigues F, Matos MJ, et al. Chronic obstructive pulmonary disease in Portugal: Pneumobil (1995) and 2002 prevalence studies revisited. Rev Port Pneumol. 2013;19:88-95. Medline:23639349 doi:10.1016/j.rppneu.2012.11.005
90. Mascarenhas J, Falcao H, Lourenco P, Paulo C, Patacho M, Bettencourt P, et al. Population-based study on the prevalence of spirometric obstructive pattern in Porto, Portugal. Respir Care. 2011;56:619-25. Medline: 21276282 doi:10.4187/respcare.00698
91. Grzetic-Romcevic T, Devcic B, Sonc S. Spirometric testing on World COPD Day. Int J Chron Obstruct Pulmon Dis. 2011;6:141-6. Medline:21468166 doi:10.2147/COPD.S16605
92. Miravitlles M, Soriano JB, Garcia-Rio F, Munoz L, Duran-Tauleria E, Sanchez G, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax. 2009;64:863-8. Medline:19553233 doi:10.1136/thx.2009.115725
93. Peńa VS, Miravitlles M, Gabriel R, Jimenez-Ruiz CA, Villasante C, Masa JF, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest. 2000;118:981-9. Medline:11035667 doi:10.1378/chest.118.4.981
94. Cabrera López C, Julia Serda G, Cabrera Lacalzada C, Martin Medina A, Gullon Blanco JA, Garcia Bello MA, et al. Prevalence of chronic obstructive pulmonary disease in the Canary Islands. Arch Bronconeumol. 2014;50:272-7. Medline:24507558 doi:10.1016/j.arbres.2013.12.006
95. Danielsson P, Olafsdottir I, Benediktsdottir B, Gislason T, Janson C. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden-the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study. Clin Respir J. 2012;6:120-7. Medline:21651748 doi:10.1111/j.1752-699X.2011.00257.x
96. Lindberg A, Bjerg A, Ronmark E, Larsson L-G, Lundback B. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking: Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med. 2006;100:264-72. Medline:15975774 doi:10.1016/j.rmed.2005.04.029
97. Lindberg A, Jonsson AC, Ronmark E, Lundgren R, Larsson LG, Lundback B. Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits. Respiration. 2005;72:471-9. Medline:16210885 doi:10.1159/000087670
98. Ekberg-Aronsson M, Lofdahl K, Nilsson J-A, Lofdahl C-G, Nilsson PM. Hospital admission rates among men and women with symptoms of chronic bronchitis and airflow limitation corresponding to the GOLD stages of chronic obstructive pulmonary disease-A population-based study. Respir Med. 2008;102:109-20. Medline:17928213 doi:10.1016/j.rmed.2007.07.028
99. Lindström M, Jonsson E, Larsson K, Lundback B. Underdiagnosis of chronic obstructive pulmonary disease in Northern Sweden. Int J Tuberc Lung Dis. 2002;6:76-84. Medline:11931405
100. Hasselgren M, Arne M, Lindahl A, Janson S, Lundback B. Estimated prevalences of respiratory symptoms, asthma and chronic obstructive pulmonary disease related to detection rate in primary health care. Scand J Prim Health Care. 2001;19:54-7. Medline:11303549 doi:10.1080/028134301300034701
101. Larsson M. Where is the borderline between asthma and "COPD"? Reflections on a diagnostic questionnaire. Lakartidningen. 1995;92:1089-92. Medline:7700110
102. Bridevaux P-O, Probst-Hensch NM, Schindler C, Curjuric I, Felber Dietrich D, Braendli O, et al. Prevalence of airflow obstruction in smokers and never-smokers in Switzerland. Eur Respir J. 2010;36:1259-69. Medline:20413537 doi:10.1183/09031936.00004110
103. Arslan Z, Ilgazli A, Etiler N, Hamzaoglu O. Prevalence of chronic obstructive pulmonary disease in Kocaeli: an industrialised city in Turkey. Balkan Med J. 2013;30:387-93. Medline:25207146 doi:10.5152/balkanmedj.2013.8042
104. Erdogan A, Yilmazel-Ucar E, Araz O, Saglam L, Mirici NA. Contribution of spirometry to early diagnosis of chronic obstructive pulmonary disease in primary health care centers. Turk J Med Sci. 2013;43:690-4.doi:10.3906/sag-1207-60
105. Deveci F, Deveci SE, Turkoglu S, Turgut T, Kirkil G, Rahman S, et al. The prevalence of chronic obstructive pulmonary disease in Elazig, Eastern Turkey. Eur J Intern Med. 2011;22:172-6. Medline:21402248 doi:10.1016/j.ejim.2010.12.014
106. Gunen H, Hacievliyagil SS, Yetkin O, Gulbas G, Mutlu LC, Pehlivan E. Prevalence of COPD: first epidemiological study of a large region in Turkey. Eur J Intern Med. 2008;19:499-504. Medline:19013377 doi:10.1016/j.ejim.2007.06.028
107. Jordan RE, Miller MR, Lam K-BH, Cheng KK, Marsh J, Adab P. Sex, susceptibility to smoking and chronic obstructive pulmonary disease: the effect of different diagnostic criteria. Analysis of the Health Survey for England. Thorax. 2012;67:600-5. Medline:22382600 doi:10.1136/thoraxjnl-2011-201384
108. Melville AM, Pless-Mulloli T, Afolabi OA, Stenton SC. COPD prevalence and its association with occupational exposures in a general population. Eur Respir J. 2010;36:488-93. Medline:20110401 doi:10.1183/09031936.00038309
109. Murtagh E, Heaney L, Gingles J, Shepherd R, Kee F, Patterson C, et al. The prevalence of obstructive lung disease in a general population sample: The NICECOPD study. Eur J Epidemiol. 2005;20:443-53. Medline:16080593 doi:10.1007/s10654-005-1248-8
110. Dickinson JA, Meaker M, Searle M, Ratcliffe G. Screening older patients for obstructive airways disease in a semi-rural practice. Thorax. 1999;54:501-5. Medline:10335003 doi:10.1136/thx.54.6.501
111. Renwick DS, Connolly MJ. Prevalence and treatment of chronic airways obstruction in adults over the age of Thorax. 1996;51:164-8. Medline:8711649 doi:10.1136/thx.51.2.164
112. Shahab L, Jarvis MJ, Britton J, West R. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax. 2006;61:1043-7. Medline:17040932 doi:10.1136/thx.2006.064410
113. de Marco R, Accordini S, Cerveri I, Corsico A, Sunyer J, Neukirch F, et al. An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages. Thorax. 2004;59:120-5. Medline:14760151 doi:10.1136/thorax.2003.011163
114. Zachariades AG, Zachariadou T, Adamide T, Anagnostopoulou U, Georgiou A, Gourgoulianis KI. Prevalence of chronic obstructive pulmonary disease in Cyprus: A population-based study. COPD. 2012;9:259-67. Medline:22432899 doi:10.3109/15412555.2011.650242
115. Islam MSHM, Pasha MM, Azad AK, Murshed KM. Prevalence and risk factors of chronic obstructive pulmonary disease (COPD) in Dhaka city population. Mymensingh Med J. 2013;22:547-51. Medline:23982547
116. Mosharraf-Hossain KM, Islam S, Kalam A, Pasha M, Sultana F, Hossain R, et al. Detection of chronic obstructive pulmonary disease using spirometric screening. Mymensingh Med J. 2009;18:S108-12. Medline:19377418
117. Maranetra KN, Dejsomritrutai W, Nana A, Naruman C, Sangkaew S, Aksornin M, et al. The prevalence and incidence of COPD among urban older persons of Bangkok Metropolis. J Med Assoc Thai. 2002;85:1147-55. Medline:12546310
118. Parasuramalu BG, Huliraj N, Prashanth Kumar S, Gangaboraiah S, Ramesh Masthi N, Srinivasa Babu C. Prevalence of chronic obstructive pulmonary disease and its association with tobacco smoking and environmental tobacco smoke exposure among rural population. Indian J Public Health. 2014;58:45-9. Medline:24748357 doi:10.4103/0019-557X.128166
119. Johnson P, Balakrishnan K, Ramaswamy P, Ghosh S, Sadhasivam M, Abirami O, et al. Prevalence of chronic obstructive pulmonary disease in rural women of Tamilnadu: implications for refining disease burden assessments attributable to household biomass combustion. Glob Health Action. 2011;4:7226. Medline:22065945
120. Mahesh PA, Jayaraj B, Prahlad S, Chaya S, Prabhakar A, Agarwal A, et al. Validation of a structured questionnaire for COPD and prevalence of COPD in rural area of Mysore: A pilot study. Lung India. 2009;26:63-9. Medline:20442838 doi:10.4103/0970-2113.53226
121. Toelle BG, Xuan W, Bird TE, Abramson MJ, Atkinson DN, Burton DL, et al. Respiratory symptoms and illness in older Australians: the Burden of Obstructive Lung Disease (BOLD) study. Med J Aust. 2013;198:144-8. Medline:23418694 doi:10.5694/mja11.11640
122. Matheson MC, Benke G, Raven J, Sim MR, Kromhout H, Vermeulen R, et al. Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease. Thorax. 2005;60:645-51. Medline:16061705 doi:10.1136/thx.2004.035170
123. Shirtcliffe P, Weatherall M, Marsh S, Travers J, Hansell A, McNaughton A, et al. COPD prevalence in a random population survey: a matter of definition. Eur Respir J. 2007;30:232-9. Medline:17666557 doi:10.1183/09031936.00157906
124. Liu SM, Wang XP, Wang DL, Zhou YM, Lu JC, Zheng JP, et al. Epidemiologic analysis of COPD in Guangdong province. Zhonghua Yi Xue Za Zhi. 2005;85:747-52. Medline:15949380
125. Zhong N, Yao W, Chen P, Kang J, Huang S, Chen B, et al. Prevalence of chronic obstructive pulmonary disease in China: A large, population-based survey. Am J Respir Crit Care Med. 2007;176:753-60. Medline:17575095 doi:10.1164/rccm.200612-1749OC
126. Qiu J, Zhang Y, Chen J, Luo T, Yu X, Wang J, et al. Prevalence of chronic obstructive pulmonary disease in Ningxia Hui Autonomous Region of China. Zhonghua Jie He He Hu Xi Za Zhi. 2013;36:265-8. Medline:23945339
127. Li Q, Liao X, Zhang Q, Wang Y, Wu X, Xu Z, et al. Epidemiological sampling survey on chronic obstructive pulmonary disease in urban area of Chongqing. Chin J Respir Crit Care Med. 2009;8:12-5.
128. Gong Y, Shi G-C, Wan H-Y, Li M, Li Q-Y, Cheng Q-J, et al. Changes in prevalences of COPD within 5 years in people aged no less than 60 years in Shanghai urban area. J Shanghai Jiaotong Univ. 2011;31:216. Med Sci.
129. Ling M, Gou AS, Niu L, Wang H, Abaydulla Z, Zhu J, et al. The risk factors for chronic obstructive pulmonary disease in Xinjiang rural areas. Zhonghua Jie He He Hu Xi Za Zhi. 2011;34:666-8. Medline:22177491
130. Zeng X-F, Che F, Wang X-X. Diagnosis and treatment of chronic obstructive pulmonary disease by general practitioners working in community hospitals of Chengdu. Chin Gen Pract. 2010;28:2010-28.
131. Liu S, Wen D, Li L, Li Z. An epidemiological study of chronic obstructive pulmonary disease in greenhouse farmers in Liaoning Province from 2006 to 2009. Zhonghua Jie He He Hu Xi Za Zhi. 2011;34:753-6. Medline:22321709
132. Liu S, Zhou Y, Wang X, Wang D, Lu J, Zheng J, et al. Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South China. Thorax. 2007;62:889-97. Medline:17483137 doi:10.1136/thx.2006.061457
133. Yu LZ, Feng YP, Mu HJ, Liu L, Yu LY, Li YX, et al. Mortality trend on chronic obstructive pulmonary disease in Liaoning province, 1984-2010. Zhonghua Liu Xing Bing Xue Za Zhi. 2012;33:399-403. Medline:22781414
134. Wang X-P, Zhou Y-M, Zeng X-Y, Liu S-M, Qiu R, Xie J-F, et al. Study on the prevalence rate of chronic obstructive pulmonary disease in northern part of Guangdong province. Zhonghua Liu Xing Bing Xue Za Zhi. 2005;26:211-3. Medline:15941513
135. Jiang RG, Luo D, Huang C, Li W. Study on the prevalence rate and risk factors of chronic obstructive pulmonary disease in rural community population in Hubei province. Zhonghua Liu Xing Bing Xue Za Zhi. 2007;28:976-9. Medline:18399143
136. Yao W-Z, Zhu H, Shen N, Han X, Liang Y-J, Zhang L-Q, et al. Epidemiological data of chronic obstructive pulmonary disease in Yanqing County in Beijing. Beijing Da Xue Xue Bao. 2005;37:121-5. Medline:15841136
137. Wang Y-C, Lin J-M, Li C-Y, Lee L-T, Guo Y-L, Sung F-C. Prevalence and risks of chronic airway obstruction: A population cohort study in Taiwan. Chest. 2007;131:705-10. Medline:17356083 doi:10.1378/chest.06-1829
138. Yin P, Jiang CQ, Cheng KK, Lam TH, Lam KH, Miller MR, et al. Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study. Lancet. 2007;370:751-7. Medline:17765524 doi:10.1016/S0140-6736(07)61378-6
139. Smith M, Li L, Augustyn M, Kurmi O, Chen J, Collins R, et al. Prevalence and correlates of airflow obstruction in ~317 000 never-smokers in China. Eur Respir J. 2014;44:66-77. Medline:24603814 doi:10.1183/09031936.00152413
140. Zhou Y, Wang C, Yao W, Chen P, Kang J, Huang S, et al. COPD in Chinese nonsmokers. Eur Respir J. 2009;33:509-18. Medline:19251797
141. Ko FWS, Woo J, Tam W, Lai CKW, Ngai J, Kwok T, et al. Prevalence and risk factors of airflow obstruction in an elderly Chinese population. Eur Respir J. 2008;32:1472-8. Medline:18684847 doi:10.1183/09031936.00058708
142. Lau AC-W, Ip MS-M, Lai CK-W, Choo K-L, Tang K-S, Yam LY-C, et al. Variability of the prevalence of undiagnosed airflow obstruction in smokers using different diagnostic criteria. Chest. 2008;133:42-8. Medline:17989159 doi:10.1378/chest.07-1434
143. Nishimura K, Mitsuma S, Kobayashi A, Yanagida M, Nakayasu K, Hasegawa Y, et al. COPD and disease-specific health status in a working population. Respir Res. 2013;14:61. Medline:23725096 doi:10.1186/1465-9921-14-61
144. Fukahori S, Matsuse H, Takamura N, Hirose H, Tsuchida T, Kawano T, et al. Prevalence of chronic obstructive pulmonary diseases in general clinics in terms of FEV1/FVC. Int J Clin Pract. 2009;63:269-74. Medline: 19196365 doi:10.1111/j.1742-1241.2008.01873.x
145. Takemura H, Hida W, Sasaki T, Sugawara T, Sen T. Prevalence of chronic obstructive pulmonary disease in Japanese people on medical check-up. Tohoku J Exp Med. 2005;207:41-50. Medline:16082154 doi:10.1620/tjem.207.41
146. Fukuchi Y, Nishimura M, Ichinose M, Adachi M, Nagai A, Kuriyama T, et al. COPD in Japan: the Nippon COPD epidemiology study. Respirology. 2004;9:458-65. Medline:15612956 doi:10.1111/j.1440-1843.2004.00637.x
147. Kojima S, Sakakibara H, Motani S, Hirose K, Mizuno F, Ito M, et al. Effects of smoking and age on chronic obstructive pulmonary disease in Japan. J Epidemiol. 2005;15:113-7. Medline:16141629 doi:10.2188/jea.15.113
148. Yoo KH, Kim YS, Sheen SS, Park JH, Hwang YI, Kim S-H, et al. Prevalence of chronic obstructive pulmonary disease in Korea: The fourth Korean National Health and Nutrition Examination Survey, 2008. Respirology. 2011;16:659-65. Medline:21342331 doi:10.1111/j.1440- 843.2011.01951.x
149. Kim SJ, Suk MH, Choi HMA, Kimm KC, Jung KH, Lee SY, et al. The local prevalence of COPD by post-bronchodilator GOLD criteria in Korea. Int J Tuberc Lung Dis. 2006;10:1393-8. Medline:17167958
150. Kim DS, Kim YS, Jung K-S, Chang JH, Lim C-M, Lee JH, et al. Prevalence of chronic obstructive pulmonary disease in Korea. Am J Respir Crit Care Med. 2005;172:842-7. Medline:15976382 doi:10.1164/rccm.200502-259OC
151. Shin C, Lee S, Abbott RD, Kim JH, Lee SY, In KH, et al. Relationships between respiratory symptoms and FEV1 in men and women with normal lung function: The Korean Health and Genome Study. Lung. 2005;183:301-9. Medline:16389723 doi:10.1007/s00408-004-2543-y
152. Fishwick D, Bradshaw LM, D'Souza W, Town I, Armstrong R, Pearce N, et al. Chronic bronchitis, shortness of breath, and airway obstruction by occupation in New Zealand. Am J Respir Crit Care Med. 1997;156:1440-6. Medline:9372658 doi:10.1164/ajrccm.156.5.97-03007
153. Idolor LF, De Guia TS, Francisco NA, Roa CC, Ayuyao FG, Tady CZ, et al. Burden of obstructive lung disease in a rural setting in the Philippines. Respirology. 2011;16:1111-8. Medline:21801277 doi:10.1111/j.1440-1843.2011.02027.x
154. Lâm HT, Ekerljung L, Tng NV, Ronmark E, Larsson K, Lundback B. Prevalence of COPD by disease severity in men and women in Northern Vietnam. COPD. 2014;11:575-81. Medline:24867392 doi:10.3109/15412555.2014.898039
155. Ko FWS, Lai CKW, Woo J, Ho SC, Ho CWM, Goggins W, et al. 12-year change in prevalence of respiratory symptoms in elderly Chinese living in Hong Kong. Respir Med. 2006;100:1598-607. Medline:16446081 doi:10.1016/j.rmed.2005.12.007
156. United Nations. World Population Prospects: The 2012 Revision. New York: United Nations, 2013. Available from: http://esa.un.org/wpp/.
157. World Health Organization. The World Health Report 2002: reducing risks, promoting healthy life. Geneva, Switzerland: WHO, 2002.
158. Regional COPD Working Group. COPD prevalence in 12 Asia-Pacific countries and regions: Projections based on the COPD prevalence estimation model. Respirology. 2003;8:192-8. Medline:12753535 doi:10.1046/ j.1440-1843.2003.00460.x
159. Chan-Yeung M, Ait-Khaled N, White N, Ip M, Tan W. The burden and impact of COPD in Asia and Africa. Int J Tuberc Lung Dis. 2004;8:2-14. Medline:14974740
160. McKay AJ, Mahesh PA, Fordham JZ, Majeed A. Prevalence of COPD in India: a systematic review. Prim Care Respir J. 2012;21:313-21. Medline:22790612 doi:10.4104/pcrj.2012.00055
161. European Commission. European Health Interview Survey: Descripion of dataset, 2014. Available from: http://ec.europa.eu/eurostat/web/microdata/european-health-interview-survey.
162. Pauwels RA, Buist AS, Calverley PMA, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163:1256-76. Medline:11316667 doi:10.1164/ajrccm.163.5.2101039
163. van Gemert F, van der Molen T, Jones R, Chavannes N. The impact of asthma and COPD in sub-Saharan Africa. Prim Care Respir J. 2011;20:240-8. Medline:21509418 doi:10.4104/pcrj.2011.00027
164. Finney LJ, Feary JR, Leonardi-Bee J, Gordon SB, Mortimer K. Chronic obstructive pulmonary disease in sub- Saharan Africa: A systematic review. Int J Tuberc Lung Dis. 2013;17:583-9. Medline:23394105 doi:10.5588/ijtld.12.0619
165. Ben Abdallah FC, Taktak S, Chtourou A, Mahouachi R, Kheder AB. Burden of chronic respiratory diseases (CRD) in Middle East and North Africa (MENA). WAO Journal. 2011;4:S6-8. Medline:23283069
166. Lopez Varela MV, Montes de Oca M, Halbert RJ, Muino A, Perez-Padilla R, Talamo C, et al. Sex-related differences in COPD in five Latin American cities: the PLATINO study. Eur Respir J. 2010;36:1034-41. Medline:20378599 doi:10.1183/09031936.00165409
167. Walker PP, Mitchell P, Diamantea F, Warburton CJ, Davies L. Effect of primary-care spirometry on the diagnosis and management of COPD. Eur Respir J. 2006;28:945-52. Medline:16870668 doi:10.1183/0903193 6.06.00019306
168. Stoilkova A, Janssen DJ, Wouters EF. Educational programmes in COPD management interventions: a systematic review. Respir Med. 2013;107:1637-50. Medline:24012387 doi:10.1016/j.rmed.2013.08.006